Siyah Gojiberry

                 

 

1-SİYAH  GOJİBERRYNİN FAYDALARI

                       Black Wolfberry- Lycium ruthenicum- Wild Black

 

•  Dağ  sırtları  olmamak kaydı  ile,  yaklaşık   1200 m rakıma  kadar (- 15 C  yetişebilmektedir.)
•  Karotenlerden B 1, B2, C  vitamini, demir, çinko, selenyum ve diğer antioksidan maddelerce zengindir.
•  Diabet  tedavisinde, anemi, görme problemleri, impotans, akciğer hastalıklarının tedavisinde, AIDS  ve kanserden  immün sistemi güçlendirerek koruma sağlar.
•  İçindeki  antioksidan, karotenoid  ve flavinoidler,  serbest radikallere karşı vücudu korur.
• ​
•  Yaşlanmayı  yavaşlatır.  
•  Menapoz   ve  kalp hastalıklarına iyi gelmektedir.  
•  Özellikle antioksidan özelliği ile hücredeki serbest oksijen radikal lerini temizler.
•  Llipid peroksidaz düzeyini azaltır.
•  Glutatyon düzeyini artırır.
•  Bilinen bir yan etkisi yoktur. (Bilimsel  makalelerden  alıntıdır)
•  

 

   2- BAHÇE KURMA (Kendi tecrübelerimiz)                                                   

•  Siyajh gojiberry bahçesinin kuruluşu,  kırmızı gojiberry den farklıdır.
•  Bu türün kuş zararlısı yoktur. Bu sebeple kuş filesine gerek yoktur.
•  Daha ziyade yatay büyür. Üzüm ocaklarının küçüğü gibi bir alan kaplaması vardır.  
•  Siyah gojiberry bahçesi kurulumunda:  Çilek bahçesi kurar gibi, fida dikim hatlarını  siyah naylonla kaplamak daha uygundur.
•  BU SİSTEMLE :
•  Damlama sistemi naylonun altında kalır.
•  Su kaybı en aza iner.
•  2-3 yıllık organik gübre bitki kök bölgesine stoklanmış olur. Azot kaybı olmaz.
•  Meyveler toz, toprak ve çamura bulaşmadan hijyenik kalır. 
• Zararlıları: (Kendi tecrübelerimiz) 
• Aşırı donlara karşı,  karşı kırmızı gojiberry kadar dayanıklı değildir. (- 15 C  lerde zarar görmeye başlamaktadır) 
• Taşsız arazilerde, çevrede köstebek var ise,  köklerine  musallat olmaktadır. Bu sebeple tabanı delik büyük saksılarda (ilk yıllarda 10 lt, sonraları 40 lt gibi) yetiştirmek tercih edilebilir. 

                                       

 

 You Tube Video:    https://www.youtube.com/watch?v=zb4j2sDoh9U   (Zafer ATİLLA)

INTERNATİONAL REFERENCES

1. Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology. 2012;17:311–21. [PubMed]

2. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24:2117–23. [PMC free article] [PubMed]

3. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis. 2010;55:660–70. [PubMed]

4. Singh D, Kaur R, Chander V, Chopra K. Antioxidants in the prevention of renal disease. J Med Food.2006;9:443–50. [PubMed]

5. Rodriguez F, Bonacasa B, Fenoy FJ, Salom MG. Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injury. Curr Pharm Des. 2013;19:2776–94. [PubMed]

6. Rodrigo R, Bosco C. Oxidative stress and protective effects of polyphenols: Comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol. 2006;142:317–27. [PubMed]

7. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74:S4–9. [PubMed]

8. Araujo M, Welch WJ. Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens.2006;15:72–7. [PubMed]

9. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4:118–26. [PMC free article] [PubMed]

10. Zheng J, Ding C, Wang L, Li G, Shi J, Li H, et al. Anthocyanins composition and antioxidant activity of wildLycium ruthenicum Murr. from Qinghai-Tibet Plateau. Food Chem. 2011;126:859–65.

11. Jia XL, Chi XF, Dong Q, Xiao YC, Hu FZ. Analysis of the nutritional components of lycium ruthenicum.Amino Acids Biotic Resour. 2011;33:60–2.

12. Cheng HJ, Hou XJ, Bai HJ, Kong XY. Analysis of several nutritional compositions from lycium ruthenicum.Chin Wild Plant Resour. 2002;21:55.

13. Chen C, Yun S, Tao Y, Mei L, Shu Q, Wang L. Main anthocyanins compositions and corresponding H-ORAC assay for wild Lycium ruthenicum Murr. fruits from the Qaidam Basin. J Pharm Tech Drug Res.2013;2:1–5.

14. Liu Z, Dang J, Wang Q, Yu M, Jiang L, Mei L, et al. Optimization of polysaccharides from Lycium ruthenicum fruit using RSM and its anti-oxidant activity. Int J Biol Macromol. 2013;61:127–34. [PubMed]

15. Perantoni A, Berman JJ. Properties of Wilms’ tumor line (TuWi) and pig kidney line (LLC-PK1) typical of normal kidney tubular epithelium. In vitro. 1979;15:446–54. [PubMed]

16. Fraga CG, Leibovitz BE, Tappel AL. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes. Free Radic Biol Med.1988;4:155–61. [PubMed]

17. Yokozawa T, Cho EJ, Hara Y, Kitani K. Antioxidative activity of green tea treated with radical initiator 2, 2’-azobis (2-amidinopropane) dihydrochloride. J Agric Food Chem. 2000;48:5068–73. [PubMed]

18. Yokozawa T, Nakagawa T, Lee KI, Cho EJ, Terasawa K, Takeuchi S. Effects of green tea tannin on cisplatin - induced nephropathy in LLC-PK1 cells and rats. J Pharm Pharmacol. 1999;51:1325–31. [PubMed]

19. Cohly HH, Taylor A, Angel MF, Salahudeen AK. Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med. 1998;24:49–54. [PubMed]

20. Costa S, Utan A, Cervellati R, Speroni E, Guerra M. Catechins: Natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1) Food Chem Toxicol. 2007;45:1910–7.[PubMed]

21. Kim YH, Kim YW, Oh YJ, Back NI, Chung SA, Chung HG, et al. Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK 1 cells and rats. Biol Pharm Bull.2006;29:2436–41. [PubMed]

22. Salahudeen AK. Role of lipid peroxidation in H2O2-induced renal epithelial (LLC-PK1) cell injury. Am J Physiol. 1995;268:F30–8. [PubMed]

23. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48:752–60. [PubMed]

24. Atamer A, Kocyigit Y, Ecder SA, Selek S, Ilhan N, Ecder T, et al. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol. 2008;21:924–30.[PubMed]

25. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, et al. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2007;28:397–404.[PubMed]

26. Imai H, Sumi D, Sakamoto H, Hanamoto A, Arai M, Chiba N, et al. Overexpression of phospholipid hydroperoxide glutathione peroxidase suppressed cell death due to oxidative damage in rat basophile leukemia cells (RBL-2H3) Biochem Biophys Res Commun. 1996;222:432–8. [PubMed]

27. Zou CG, Agar NS, Jones GL. Oxidative insult to human red blood cells induced by free radical initiator AAPH and its inhibition by a commercial antioxidant mixture. Life Sci. 2001;69:75–86. [PubMed]

28. Elisia I, Kitts DD. Anthocyanins inhibit peroxyl radical-induced apoptosis in Caco-2 cells. Mol Cell Biochem.2008;312:139–45. [PubMed]

29. Kusumoto C, Kinugawa T, Morikawa H, Teraoka M, Nishida T, Murawaki Y, et al. Protection by exogenously added coenzyme Q9 against free radical-induced injuries in human liver cells. J Clin Biochem Nutr.2010;46:244–51. [PMC free article] [PubMed]

30. Schnellmann RG. Renal mitochondrial glutathione transport. Life Sci. 1991;49:393–8. [PubMed]

31. Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DC. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol. 1991;28:277–82. [PubMed]

32. Zhang JG, Lindup WE. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol. 1993;45:2215–22. [PubMed]

33. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489–92. [PubMed]

34. Santos NA, Catão CS, Martins NM, Curti C, Bianchi ML, Santos AC. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol. 2007;81:495–504. [PubMed]

35. Guerrero-Beltrán CE, Calderón-Oliver M, Martínez-Abundis E, Tapia E, Zarco-Márquez G, Zazueta C, et al. Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD (P) H: Quinone oxidoreductase 1 and γ glutamyl cysteine ligase: Studies in mitochondria isolated from rat kidney and in LLC-PK1 cells. Toxicol Lett. 2010;199:80–92. [PubMed]

36. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89. [PubMed]

37. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: Importance of superoxide. J Am Soc Nephrol. 2001;12:2683–90. [PubMed]

38. Thamilselvan S, Byer KJ, Hackett RL, Khan SR. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol. 2000;164:224–9.[PubMed]

39. Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res.2005;33:349–57. [PubMed]

40. Kim YH, Choi JH, Rim HK, Kang HJ, Chang SG, Park JH, et al. 23-Hydroxytormentic acid and Niga-Ichgoside F 1 isolated from rubus coreanus attenuate cisplatin-induced cytotoxicity by reducing oxidative stress in renal epithelial LLC-PK 1 Cells. Biol Pharm Bull. 2011;34:906–11. [PubMed]